2nd Quarter - Report
THE MCMANUS GROUP for GENENTECH
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare coverage and payment of Part B drugs and biologicals. Support for H.R.452 Medicare Decisions Accountability Act of 2011 and S.668 Health Care Bureaucrats Elimination Act.
Foreign entity interest: 100% ownership by Roche Holding Ltd., 4070 Basel, Switzerland.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| NICK SHIPLEY | Legislative Director, Rep. Jay Inslee |
Health Issues HCR
FDA approval and enforcement issues.
Foreign entity interest: 100% ownership by Roche Holding Ltd., 4070 Basel Switzerland.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| NICK SHIPLEY | Legislative Director, Rep. Jay Inslee |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.